Yvonne L. Greenstreet
2020
Compensation breakdown
| Non-Equity Incentive Plan | $434,736 |
|---|---|
| Option Awards | $1,798,843 |
| Salary | $621,500 |
| Other | $178,922 |
| Total | $3,034,001 |
Greenstreet received $1.8M in option awards, accounting for 59% of the total pay in 2020.
Greenstreet also received $434.7K in non-equity incentive plan, $621.5K in salary and $178.9K in other compensation.
Rankings
In 2020, Yvonne L. Greenstreet's compensation ranked 3,814th out of 13,090 executives tracked by ExecPay. In other words, Greenstreet earned more than 70.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,814 out of 13,090 | 71st |
Division Manufacturing | 1,516 out of 5,620 | 73rd |
Major group Chemicals And Allied Products | 568 out of 2,253 | 75th |
Industry group Drugs | 488 out of 1,953 | 75th |
Industry Pharmaceutical Preparations | 368 out of 1,458 | 75th |
Pay ratio
| Yvonne L. Greenstreet's Pay | $3,034,001 |
|---|---|
| Median Employee's Pay | $233,341 |
| Pay Ratio | 13to 1 |
In 2020, the annual total compensation of Yvonne L. Greenstreet was $3,034,001.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $233,341.
The ratio of Yvonne L. Greenstreet's pay to the pay of median employee was therefore 13 to one.
Greenstreet's colleagues
We found five more compensation records of executives who worked with Yvonne L. Greenstreet at Alnylam Pharmaceuticals in 2020.
2020
Barry Greene
Alnylam Pharmaceuticals
Former President
2020
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2020
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2020
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2020
Laurie Keating
Alnylam Pharmaceuticals